cytidylyl-3',5'-adenosine has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auchampach, JA; Caughey, GH; Jin, X; Linden, J; Wan, TC | 1 |
| Carr, CS; Hill, RJ; Kennedy, SP; Knight, DR; Masamune, H; Tracey, WR; Yellon, DM | 1 |
2 other study(ies) available for cytidylyl-3',5'-adenosine and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
| Article | Year |
|---|---|
Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Topics: Adenine; Adenosine; Amino Acid Sequence; Animals; Base Sequence; beta-N-Acetylhexosaminidases; Calcium; Chlorocebus aethiops; COS Cells; Dinucleoside Phosphates; DNA, Complementary; Dogs; Mast Cells; Mast-Cell Sarcoma; Molecular Sequence Data; Neoplasm Proteins; Norbornanes; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Xanthines | 1997 |
Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.
Topics: Adenosine; Dinucleoside Phosphates; Heart Atria; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Models, Biological; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines | 1997 |